Next Article in Journal
Combined Supplementation of Pre-Exercise Carbohydrate, Alanine, and Proline and Continuous Intake of Green Tea Catechins Effectively Boost Endurance Performance in Mice
Previous Article in Journal
Testing the Feasibility and Preliminary Efficacy of an 8-Week Exercise and Compensatory Eating Intervention
Article Menu
Issue 7 (July) cover image

Export Article

Open AccessArticle
Nutrients 2018, 10(7), 924; https://doi.org/10.3390/nu10070924

“Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial

1
Department of Internal Medicine (I), Osaka Medical College, 2-7 Daigaku-machi, Takatsuki 569-8686, Japan
2
National Agriculture and Food Research Organization, Agri-Food Business Innovation Center, 3-1-1 Kannondai, Tsukuba 305-8517, Japan
3
Division of Applied Biological Chemistry, Department of Bioscience and Biotechnology, Faculty of Agriculture, Kyushu University, 6-10-1 Hakozaki, Higashi-ku, Fukuoka 812-8581, Japan
4
Sakai City Medical Center, 1-1-1 Ebaraji-cho, Nishi-ku, Sakai 593-8304, Japan
*
Author to whom correspondence should be addressed.
Received: 18 June 2018 / Revised: 14 July 2018 / Accepted: 17 July 2018 / Published: 19 July 2018
Full-Text   |   PDF [958 KB, uploaded 19 July 2018]   |  

Abstract

(1) Background: Arteriosclerosis is associated with high levels of low-density lipoprotein (LDL) cholesterol. O-methylated catechins in “Benifuuki” green tea are expected to reduce cholesterol levels, although there is limited research regarding this topic; (2) Methods: This trial evaluated 159 healthy volunteers who were randomized to receive ice cream containing a high-dose of “Benifuuki” extract including 676 mg of catechins (group H), a low-dose of “Benifuuki” extract including 322 mg of catechins (group L), or no “Benifuuki” extract (group C). Each group consumed ice cream (with or without extract) daily for 12 weeks, and their lipid-related parameters were compared; (3) Results: A significant reduction in the level of lectin-like oxidized LDL receptor-1 ligand containing ApoB (LAB) was detected in group H, compared to groups L and C. No significant differences between the three groups were detected in their levels of total cholesterol, triglycerides, and LDL cholesterol; (4) Conclusions: “Benifuuki” extract containing O-methylated catechins may help prevent arteriosclerosis. View Full-Text
Keywords: dyslipidemia; Benifuuki; O-methylated catechin; Lectin-like oxidized LDL receptor-1; LOX-1 ligand dyslipidemia; Benifuuki; O-methylated catechin; Lectin-like oxidized LDL receptor-1; LOX-1 ligand
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

SciFeed

Share & Cite This Article

MDPI and ACS Style

Miyawaki, M.; Sano, H.; Imbe, H.; Fujisawa, R.; Tanimoto, K.; Terasaki, J.; Maeda-Yamamoto, M.; Tachibana, H.; Hanafusa, T.; Imagawa, A. “Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial. Nutrients 2018, 10, 924.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top